biote Corp. BTMD
1.22
(0.01)
(0.81%)
as of 25 Sep
- Market cap
- $44.2M
- P/E
- 7.8×
Follow BTMD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(29.95%) | (35.45%) | (23.50%) | (8.55%) | |
| 27.09% | 23.52% | 14.69% | 5.67% | ||
ROIC |
199.50% | 68.34% | 34.62% | 17.68% | |
Return on Tangible Assets |
264.70% | 132.37% | 82.86% | 22.71% | |
Average Days of Receivables |
14.87 | 13.04 | 14.35 | 15.53 | |
Free Cash Flow per Share |
1.10 | 0.91 | 0.86 | 0.61 | |
Free Cash Flow |
34.41 | 28.33 | 26.45 | 17.52 | |
Capital Expenditures |
(5.58) | (6.86) | (6.18) | (6.85) | |
Piotroski F-Score |
7.00 | 6.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
60.63% | 43.58% | 51.76% | 32.72% | |
Accounts Receivable Turnover |
23.77 | 26.51 | 24.82 | 21.74 | |
Accounts Payable Turnover |
12.38 | 8.68 | 9.72 | 11.05 | |
Inventory Turnover |
3.31 | 3.24 | 3.37 | 3.79 | |
Average Days of Payables |
29.43 | 45.42 | 53.46 | 41.62 | |
Days of Inventory on Hand |
111.04 | 126.84 | 129.05 | 116.02 | |
Tax Rate |
0.06 | (0.16) | (0.21) | (0.31) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
56.27% | 52.97% | 54.69% | 60.54% | |
Share Based Compensation of Revenue |
4.40% | 4.64% | 4.55% | 4.54% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.39 | 1.30 | 2.09 | 4.16 | |
Depreciation/Fixed assets |
0.47 | 0.42 | 0.43 | 0.36 | |
Capex/Depreciation |
(1.19) | (1.52) | (1.34) | (1.47) | |
Revenue per Share |
6.24 | 6.14 | 6.14 | 6.41 | |
Operating CF per Share |
1.28 | 1.13 | 1.06 | 0.85 | |
Capex per Share |
(0.18) | (0.22) | (0.20) | (0.24) | |
Capex to Sales |
0.03 | 0.04 | 0.03 | 0.04 | |
Net Profit Margin |
14.72% | 14.07% | 8.29% | 3.19% |
Columns are period end dates